These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 10504490)

  • 1. TGF-beta-activating kinase-1 inhibits cell cycle and expression of cyclin D1 and A in LLC-PK1 cells.
    Terada Y; Nakashima O; Inoshita S; Kuwahara M; Sasaki S; Marumo F
    Kidney Int; 1999 Oct; 56(4):1378-90. PubMed ID: 10504490
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mitogen-activated protein kinase cascade and transcription factors: the opposite role of MKK3/6-p38K and MKK1-MAPK.
    Terada Y; Nakashima O; Inoshita S; Kuwahara M; Sasaki S; Marumo F
    Nephrol Dial Transplant; 1999; 14 Suppl 1():45-7. PubMed ID: 10048449
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of cyclin D1 expression and cell cycle progression by mitogen-activated protein kinase cascade.
    Terada Y; Inoshita S; Nakashima O; Kuwahara M; Sasaki S; Marumo F
    Kidney Int; 1999 Oct; 56(4):1258-61. PubMed ID: 10504469
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclin D1 expression is regulated positively by the p42/p44MAPK and negatively by the p38/HOGMAPK pathway.
    Lavoie JN; L'Allemain G; Brunet A; Müller R; Pouysségur J
    J Biol Chem; 1996 Aug; 271(34):20608-16. PubMed ID: 8702807
    [TBL] [Abstract][Full Text] [Related]  

  • 5. p38 MAP kinase negatively regulates cyclin D1 expression in airway smooth muscle cells.
    Page K; Li J; Hershenson MB
    Am J Physiol Lung Cell Mol Physiol; 2001 May; 280(5):L955-64. PubMed ID: 11290520
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Delta MEKK3:ER* activation induces a p38 alpha/beta 2-dependent cell cycle arrest at the G2 checkpoint.
    Garner AP; Weston CR; Todd DE; Balmanno K; Cook SJ
    Oncogene; 2002 Nov; 21(53):8089-104. PubMed ID: 12444545
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transforming growth factor-beta1 (TGF-beta)-induced apoptosis of prostate cancer cells involves Smad7-dependent activation of p38 by TGF-beta-activated kinase 1 and mitogen-activated protein kinase kinase 3.
    Edlund S; Bu S; Schuster N; Aspenström P; Heuchel R; Heldin NE; ten Dijke P; Heldin CH; Landström M
    Mol Biol Cell; 2003 Feb; 14(2):529-44. PubMed ID: 12589052
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TGF-beta-activated kinase 1 and TAK1-binding protein 1 cooperate to mediate TGF-beta1-induced MKK3-p38 MAPK activation and stimulation of type I collagen.
    Kim SI; Kwak JH; Zachariah M; He Y; Wang L; Choi ME
    Am J Physiol Renal Physiol; 2007 May; 292(5):F1471-8. PubMed ID: 17299140
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aldosterone stimulates proliferation of mesangial cells by activating mitogen-activated protein kinase 1/2, cyclin D1, and cyclin A.
    Terada Y; Kobayashi T; Kuwana H; Tanaka H; Inoshita S; Kuwahara M; Sasaki S
    J Am Soc Nephrol; 2005 Aug; 16(8):2296-305. PubMed ID: 15975997
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estrogens do not modify MAP kinase-dependent nuclear signaling during stimulation of early G(1) progression in human breast cancer cells.
    Caristi S; Galera JL; Matarese F; Imai M; Caporali S; Cancemi M; Altucci L; Cicatiello L; Teti D; Bresciani F; Weisz A
    Cancer Res; 2001 Sep; 61(17):6360-6. PubMed ID: 11522626
    [TBL] [Abstract][Full Text] [Related]  

  • 11. p38 mitogen-activated protein kinase-dependent activation of protein phosphatases 1 and 2A inhibits MEK1 and MEK2 activity and collagenase 1 (MMP-1) gene expression.
    Westermarck J; Li SP; Kallunki T; Han J; Kähäri VM
    Mol Cell Biol; 2001 Apr; 21(7):2373-83. PubMed ID: 11259586
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disruption of the actin cytoskeleton leads to inhibition of mitogen-induced cyclin E expression, Cdk2 phosphorylation, and nuclear accumulation of the retinoblastoma protein-related p107 protein.
    Reshetnikova G; Barkan R; Popov B; Nikolsky N; Chang LS
    Exp Cell Res; 2000 Aug; 259(1):35-53. PubMed ID: 10942577
    [TBL] [Abstract][Full Text] [Related]  

  • 13. p38 MAPK and MAPK kinase 3/6 mRNA and activities are increased in early diabetic glomeruli.
    Kang SW; Adler SG; Lapage J; Natarajan R
    Kidney Int; 2001 Aug; 60(2):543-52. PubMed ID: 11473637
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell-type-specific activation of p38 protein kinase cascades by the novel tumor promoter palytoxin.
    Li S; Wattenberg EV
    Toxicol Appl Pharmacol; 1999 Oct; 160(2):109-19. PubMed ID: 10527909
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Roles of E2F1 in mesangial cell proliferation in vitro.
    Inoshita S; Terada Y; Nakashima O; Kuwahara M; Sasaki S; Marumo F
    Kidney Int; 1999 Dec; 56(6):2085-95. PubMed ID: 10594784
    [TBL] [Abstract][Full Text] [Related]  

  • 16. G alpha(i-2) mediates renal LLC-PK1 growth by a Raf-independent activation of p42/p44 MAP kinase.
    Kinane TB; Kang I; Chu A; Chin SH; Ercolani L
    Am J Physiol; 1997 Feb; 272(2 Pt 2):F273-82. PubMed ID: 9124407
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cell cycle inhibitors (p27Kip1 and p21CIP1) cause hypertrophy in LLC-PK1 cells.
    Terada Y; Inoshita S; Nakashima O; Tamamori M; Ito H; Kuwahara M; Sasaki S; Marumo F
    Kidney Int; 1999 Aug; 56(2):494-501. PubMed ID: 10432388
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ras participates in the activation of p38 MAPK by interleukin-1 by associating with IRAK, IRAK2, TRAF6, and TAK-1.
    McDermott EP; O'Neill LA
    J Biol Chem; 2002 Mar; 277(10):7808-15. PubMed ID: 11744690
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of mitogen-activated protein kinase in taxol-induced apoptosis in human leukemic U937 cells.
    Lieu CH; Liu CC; Yu TH; Chen KD; Chang YN; Lai YK
    Cell Growth Differ; 1998 Sep; 9(9):767-76. PubMed ID: 9751120
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An anchorage-dependent signal distinct from p42/44 MAP kinase activation is required for cell cycle progression.
    Le Gall M; Grall D; Chambard JC; Pouysségur J; Van Obberghen-Schilling E
    Oncogene; 1998 Sep; 17(10):1271-7. PubMed ID: 9771970
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.